Up a level |
Number of items: 1.
Munir, T, Howard, DR, McParland, L, Pocock, C, Rawstron, AC, Hockaday, A, Varghese, A, Hamblin, M, Bloor, A, Pettitt, A et al (show 5 more authors)
(2017)
Results of the randomized phase IIB ADMIRE trial of FCR with or without mitoxantrone in previously untreated CLL.
LEUKEMIA, 31 (10).
pp. 2085-2093.